Feasibility studies minimize the risk of false negatives in large scale research

Make your research foolproof

Many natural products enter the clinical research process as phase 2 clinical trials. However, to fully capture the benefits of advanced studies, you must first have scientific confirmation of the dose or serving size, the known effects, and the time required to see results. Without this knowledge, a large-scale clinical trial could result in disastrous effects due to simple errors.

The most cost effective way to evaluate a product’s efficacy is to conduct small-scale feasibility studies or pilot studies before entering into large-scale clinical trials. These studies protect your long-term investments and help you achieve the end goal of product substantiation much faster.

Feasibility studies identify:

  • The minimum dose or serving size required to produce measurable effects
  • The target population for your product (i.e. the population which sees the greatest results)
  • The most prominent effects that can be documented from your product
  • The shortest amount of time required to see measurable health benefits
  • The frequency of exposure, dosing, or administration of your product required to produce benefits

Maximize your investment

Collectively, feasibility studies reduce the risk of error in large-scale research by ensuring your clinical trials will not be conducted on the wrong dose, the wrong population, or for the wrong duration. These provide you with a realistic overview of the potential for success in large-scale clinical research, allowing modifications to dosing, exposure, or even formulation to take place before expensive studies are conducted.